Citations

Clear

5 citation(s) found for "Grandjean, Danielle".

Defending the Ethical Permissibility of Laryngeal Transplantation
Lott, David G. , Ellertson, Marka , Grandjean, Danielle N. , Sj, Zacharias, Strome, Marshall, Beck, Annika T., Teven, Chad M., Zacharias, Stephanie R, Sharp, Richard R , Ellertson, Marka F. , Lott, David G , Zacharias, Stephanie R., Teven, Chad M. , Sharp, Richard R.

Mayo Clinic

The American Journal of Bioethics | June 30, 2026 | Volume: No volume available | Issue: No issue available | Pages: 1-8

10.1080/15265161.2026.2691944 | PMID 42377982 Get It

Strategic Development of a Larynx and Trachea Transplantation Program: The Mayo Clinic Arizona Experience
Zacharias, Stephanie R. C. , Grandjean, Danielle, Stearns, Elizabeth, Mour, Girish , Mour, Girish K , Lott, David G.

Mayo Clinic

Clinical Transplantation | March 11, 2025 | Volume: 39 | Issue: 3 | Pages: No page available

10.1111/ctr.70126 | PMID 40062927 Get It

ABSTRACTMedical advances have enabled the realization of vascularized composite allografts and to date have demonstrated reasonably successful graft survival rates. Larynx and Trachea Transplantation (LT) has long been contemplated as a therapeutic option for severe laryngeal trauma and patients following total laryngectomy. Progress has been limited most likely due to lack of awareness as an option, technical and surgical expertise, limited transplant centers worldwide, need for multidisciplinary engagement from hospital leadership, Otolaryngology, and transplant medicine to build a successful program. As one of the first programs to exist in the United States, we have had to create new pathways, develop new workflows, work with numerous regulatory bodies, educate many people about the need for an LT, and learn many lessons along the way. The objectives of this paper are to help others navigate the complexities of creating a new LT transplant program so that this important treatment option may become more available to patients worldwide. We will provide a checklist for developing an LT program and discuss our experiences with the strategic development of an LT transplant program in an academic medical institution.
P1.1: Laryngotracheal transplant: Patient and caregivers’ beliefs and perceptions
Grandjean, Danielle, Cotton-Zacharias, Stephanie, Weir, Isabel B. , Lott, David G. , Sharp, Richard R. , Curtis, Susan

Mayo Clinic

Transplantation | October 13, 2023 | Volume: 107 | Issue: 10S1 | Pages: 78-78

10.1097/01.tp.0000993444.58789.55 Get It

Idiopathic Subglottic Stenosis Is Associated With More Frequent and Abnormal Squamous Metaplasia
Tchoukalova, Yourka D. , Phung, Tanya N. , Kennedy, Maeve M. , Miranda-Grandjean, Danielle, Becquer, Emanuel, Zhang, Nan , Dinu, Valentin , Lott, David G. , Lott, David G , Dinu, Valentin , Tchoukalova, Yourka , Chen, Longwen , Wilson, Melissa A.

Mayo Clinic

Annals of Otology, Rhinology & Laryngology | September 23, 2023 | Volume: 133 | Issue: 2 | Pages: 214-223

10.1177/00034894231201016 | PMID 37740367 Get It

Objectives: Gain insights into the pathophysiology of idiopathic subglottic stenosis (iSGS) by investigating differences in transcriptome of subglottic mucosal tissue between patients with iSGS and controls, and between tracheal and subglottic tissue within patients. Methods: RNA sequencing was conducted on biopsied mucosal samples collected from subglottic and tracheal (in-patient control) regions in iSGS patients, and from subglottis in controls. The gene expression differences were validated on a protein level by (1) staining the tissue samples obtained from a second cohort of patients and controls; and (2) in vitro functional assays using primary subglottic epithelial cells from both iSGS patients and healthy donors. Results: We found 7 upregulated genes in the subglottic region of iSGS patients relative to both the tracheal mucosa and subglottic region of controls. A gene ontology enrichment analysis found that the epithelial cell differentiation and cornification pathways are significant, involving specifically 3 of the genes: involucrin ( IVL), small proline rich protein 1B ( SPRR1B), and keratin 16 ( KRT16). Involvement of these pathways suggests squamous metaplasia of the epithelium. Histological analyses of epithelium in subglottic mucosal biopsies revealed squamous metaplasia in 41% of the samples from iSGS patients and in 25% from controls. Immunohistochemical evaluation of the samples presented with squamous epithelium revealed increased expression of the protein encoded by SPRR1B, hyperproliferative basal cells, shedding of apical layers, and accompanying lesions in iSGS compared to CTRL. Cultured primary subglottic epithelial cells from iSGS patients had higher proliferation rates compared to healthy donors and squamous metaplastic differentiation formed thinner epithelia with increased expression proteins encoded by INV, SPRR1B, and KRT16, suggesting intrinsic dysfunction of basal cells in iSGS. Conclusions: Abnormal squamous differentiation of epithelial cells may contribute to the pathogenesis of iSGS. Patients having metaplastic epithelial phenotype may be sensitive to drugs that reverse it to a normal phenotype.
A Tissue Engineered Construct for Laryngeal Regeneration: A Proof‐of‐Concept Device Design Study
Shah, Manisha , Myers, Cheryl , McPhail, Michael, Neubauer, Juergen, Struthers, Jason D. , Madsen, Cathy S., Grandjean, Danielle, Zacharias, Stephanie R. C. , Tchoukalova, Yourka D. , Lott, David G , Tchoukalova, Yourka , Myers, Cheryl E , Lott, David G.

Mayo Clinic

The Laryngoscope | January 27, 2022 | Volume: 132 | Issue: S9 | Pages: No page available

10.1002/lary.30029 | PMID 35084750 Get It

Objectives/HypothesisDevelop a patient‐specific tissue engineered construct for laryngeal reconstruction following a partial laryngectomy.Study DesignBench and animal research.MethodsA construct made from a porous polyethylene scaffold shaped in a canine‐specific configuration and seeded with autologous canine adipose‐derived stem cells in fibrin glue was implanted in a canine following a partial laryngectomy. After 1 year, the construct was first evaluated in vivo with high‐speed imaging and acoustic–aerodynamic measures. It was then explanted and evaluated histologically.ResultsThe canine study at 1 year revealed the construct provided voicing (barking) with acoustic and aerodynamic measures within normal ranges. The canine was able to eat and breathe normally without long‐term support. The construct was integrated with epithelialization of all areas except the medial portion of the vocal fold structure. No anti‐infective agents were needed after the standard perioperative medications were completed.ConclusionThis study provided a successful first step toward developing a patient‐specific composite construct for patients undergoing partial laryngectomies.Level of EvidenceNA Laryngoscope, 132:S1–S11, 2022